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ABSTRACT. Ultrasound (US) has great potential as an outcome in rheumatoid arthritis trials for detecting bone
erosions, synovitis, tendon disease, and enthesopathy. It has a number of distinct advantages over
magnetic resonance imaging, including good patient tolerability and ability to scan multiple joints in
a short period of time. However, there are scarce data regarding its validity, reproducibility, and
responsiveness to change, making interpretation and comparison of studies difficult. In particular,
there are limited data describing standardized scanning methodology and standardized definitions of
US pathologies. This article presents the first report from the OMERACT ultrasound special inter-
est group, which has compared US against the criteria of the OMERACT filter. Also proposed for
the first time are consensus US definitions for common pathological lesions seen in patients with
inflammatory arthritis. (J Rheumatol 2005;32:2485–7)
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Ultrasound (US) has been used for the investigation and
management of patients with musculoskeletal disease for at
least 30 years1. Its initial use was limited to investigating
larger joints and soft tissue structures such as Baker’s cysts.
Technological improvements in the early 1990s, however,
greatly improved image resolution and tissue contrast and
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allowed access to the smaller joints2. In rheumatology, its
use has recently been directed towards the assessment of
patients with inflammatory arthritis3. This includes the
detection of bone erosions, synovitis, tendon disease, and
enthesopathy. US has a number of distinct advantages over
magnetic resonance imaging (MRI), including its ability to
scan multiple joints in a brief period of time. Additionally,
patient tolerability is good, and the rheumatologist with clin-
ical understanding of the patient’s problem can scan in the
clinic (rather than sending the patient for another appoint-
ment), thereby allowing rapid interpretation of the images
and immediate decision-making.
US, however, is often perceived as an imperfect and
operator-dependent tool. This is compounded by a lack of
data regarding its validity, reproducibility, and responsive-
ness to change, making interpretation and comparison of
studies difficult. In particular, there are limited data describ-
ing standardized scanning methodology4 and standardized
definitions of US pathologies. As a result of these difficul-
ties, a group of interested international ultrasonographers
came together under the auspices of OMERACT.
Prior to OMERACT 7
Support for a future OMERACT group was decided at the
EULAR Working Party for Ultrasound meeting held at the
2003 EULAR conference in Lisbon. A subsequent meeting
was held in Orlando in October 2003 during the American
College of Rheumatology meeting. There was general
agreement that in the first instance, the focus of the group
should be on those features commonly measured by ultra-
sonographers in inflammatory arthritis. In order to address
US issues using the OMERACT filter, it was further decid-
ed that 2 preliminary exercises would be performed prior to
the OMERACT 7 meeting.
Exercise 1. To conduct a systematic literature review, simi-
lar to that performed by members of the OMERACT MRI
group5, focusing on erosions, synovitis, tenosynovitis, and
enthesopathy at specific anatomical regions. Leaders were
nominated to coordinate a multicenter group for each litera-
ture search. The following anatomical areas were considered
most important: shoulder, hand, wrist, elbow, knee, forefoot,
ankle, and hindfoot. Pubmed and Medline searches between
1980 and April 2004 were used for the majority of searches.
Exclusions included non-English language articles, reviews,
letters, and pediatric publications.
Exercise 2. To achieve consensus on pathological US defi-
nitions. A questionnaire was distributed to the group asking
for individual definitions of common pathological lesions
seen in patients with inflammatory arthritis. These were
coordinated at one site and draft consensus definitions
obtained.
At OMERACT 7
The US special interest group (SIG) offered the opportunity
for presentation of the results of the different anatomical site
literature reviews as well as the draft definitions obtained
from the questionnaires. The group then met on 2 further
occasions during the meeting to discuss the results of the
exercises (including review of methodologies), achieve con-
sensus on the definitions, and plan the future research
agenda.
Exercise 1. Literature reviews. A large amount of literature
was reviewed and it is intended that the results will be pub-
lished separately. The following general comments can be
made:
1. The hand was the most studied area and synovitis most
studied pathology.
2. There was a paucity of validity data in terms of compar-
ison with histology and MRI, although these data are
increasing.
3. There was a paucity of reliability data. Interobserver reli-
ability was the most investigated area, with scarce data relat-
ing to intraobserver, and virtually none relating to interma-
chine reliability. Reliability exercises were also often per-
formed on different joints within the same study, making
interpretation difficult.
4. Data on normal joint structures are scarce.
5. Longitudinal and blinded studies assessing responsive-
ness to therapies are scarce.
Exercise 2. Questions on definitions and methods of scoring
for erosions, synovitis, tenosynovitis, and enthesopathy.
These definitions served as a basis for the 2 further meetings
held at OMERACT 7 to form a consensus. As some col-
leagues were unable to attend, the definitions were recircu-
lated to all members for their comments. The following def-
initions were agreed on.
RA Bone Erosion
An intraarticular discontinuity of the bone surface that is
visible in 2 perpendicular planes.
Synovial Fluid
Abnormal hypoechoic or anechoic (relative to subdermal
fat, but sometimes may be isoechoic or hyperechoic) intraar-
ticular material that is displaceable and compressible, but
does not exhibit Doppler signal.
Synovial Hypertrophy
Abnormal hypoechoic (relative to subdermal fat, but some-
times may be isoechoic or hyperechoic) intraarticular tissue
that is nondisplaceable and poorly compressible and which
may exhibit Doppler signal.
Tenosynovitis
Hypoechoic or anechoic thickened tissue with or with-
out fluid within the tendon sheath, which is seen in 2
perpendicular planes and which may exhibit Doppler
signal.
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Enthesopathy
Abnormally hypoechoic (loss of normal fibrillar architec-
ture) and/or thickened tendon or ligament at its bony attach-
ment (may occasionally contain hyperechoic foci consistent
with calcification), seen in 2 perpendicular planes that may
exhibit Doppler signal and/or bony changes including enthe-
sophytes, erosions, or irregularity.
Summary and Future Directions
US has many characteristics that make it potentially valu-
able for the investigation of the musculoskeletal system and
in particular as a hands-on clinical tool. However, scarce
data regarding important methodological and measurement
issues need to be augmented before US will gain wider
acceptance. Issues include lack of validation and reliability
data, in addition to the role of US in assessing responsive-
ness to change. The group meeting at OMERACT 7
achieved a consensus on broad descriptive US definitions. It
is possible, however, that as new data become available and
technologies advance these may have to be modified.
A detailed research agenda includes testing the reliabili-
ty of image acquisition and static image interpretation using
the new OMERACT definitions, and testing intermachine
reliability.
Although there is much work to be done, the OMERACT
process has provided an excellent framework for ongoing
collaborative studies on measurement issues.
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